Enovis Corporation operates as a medical technology company. The Company develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Enovis serves customers worldwide.

Current Report (Form 8-K | Period ending 2024-11-06)

Quarterly Report (Form 10-Q | Period ending 2024-09-27)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Enovis (ENOV US)

Current Report (Form 8-K | Period ending 2024-11-06)

Quarterly Report (Form 10-Q | Period ending 2024-09-27)

Quarterly Report (Form 10-Q | Period ending 2024-06-28)

Current Report (Form 8-K | Period ending 2024-08-07)

Current Report (Form 8-K | Period ending 2024-07-18)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)